News

Recent news about Panacea Capital and select portfolio companies

January 26, 2026

Understanding the US FDA’s Special Designations and Approval Pathways

Recognizing the challenges of drug development, the US FDA has established several special designations and…

January 26, 2026

Understanding the US FDA’s Special Designations and Approval Pathways

Recognizing the challenges of drug development, the US FDA has established several special designations and…

January 26, 2026

Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan

Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…

January 26, 2026

Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan

Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…

January 26, 2026

Leveraging China to Maximize Global Study Impact

China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…

January 26, 2026

Leveraging China to Maximize Global Study Impact

China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…

January 26, 2026

Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

January 26, 2026

Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

January 15, 2026

citybiz – Questions & Answers with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics

January 15, 2026

citybiz – Questions & Answers with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics